Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACVRL1 | P37023 | 3/20 | 0.61 |
| ▸ | GSK3B | P49841 | 11/20 | 0.57 |
| ▸ | GSK3A | P49840 | 2/20 | 0.56 |
| ▸ | MAPK14 | Q16539 | 4/20 | 0.56 |
| ▸ | PIK3C3 | Q8NEB9 | 3/20 | 0.56 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.55 |
| ▸ | MAPK10 | P53779 | 2/20 | 0.55 |
| ▸ | JAK2 | O60674 | 1/20 | 0.53 |
| ▸ | JAK1 | P23458 | 1/20 | 0.53 |
| ▸ | TYK2 | P29597 | 1/20 | 0.53 |
| ▸ | CDK9 | P50750 | 1/20 | 0.53 |
| ▸ | JAK3 | P52333 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31521720 | 1.00 | ACVRL1 (0.61) | ACVRL1GSK3BGSK3AMAPK14PIK3C3 | |
| SCHEMBL27873522 | 0.81 | ACVRL1 (0.63) | ACVRL1GSK3BGSK3AMAPK14PIK3C3 | |
| SCHEMBL15542541 | 0.81 | ACVRL1 (0.63) | ACVRL1GSK3BGSK3APIK3C3JAK2 | |
| SCHEMBL17539612 | 0.80 | ACVRL1 (0.62) | ACVRL1GSK3BGSK3APIK3C3JAK2 | |
| SCHEMBL15542212 | 0.80 | ABL1 (0.62) | ACVRL1GSK3BGSK3APIK3C3JAK2 | |
| SCHEMBL29366775 | 0.80 | ACVRL1 (0.62) | ACVRL1GSK3BGSK3APIK3C3JAK2 | |
| SCHEMBL10352589 | 0.80 | ACVRL1 (0.61) | ACVRL1GSK3BPIK3C3MAPT | |
| SCHEMBL22659338 | 0.80 | ACVRL1 (0.66) | ACVRL1GSK3BGSK3APIK3C3JAK2 | |
| SCHEMBL17377666 | 0.80 | ACVRL1 (0.61) | ACVRL1GSK3BPIK3C3JAK2JAK1 | |
| SCHEMBL24932207 | 0.80 | KDR (0.63) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3880671-B1 | NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | HK INNO N CORP (KR) | 2025-03-12 | — | — | EP | disclosed |
| US-12180185-B2 | Compound as protein kinase inhibitor, and pharmaceutical composition comprising thereof | HK INNO.N CORPORATION (KR) | 2024-12-31 | — | — | US | disclosed |
| US-20220009902-A1 | NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | HK INNO.N CORPORATION (KR) | 2022-01-13 | — | — | US | disclosed |
| US-20220009902-A1 | NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | HK INNO.N CORPORATION (KR) | 2022-01-13 | — | — | US | disclosed |
| EP-3880671-A1 | NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | HK inno.N Corporation (KR) | 2021-09-22 | — | — | EP | disclosed |
| CN-113166094-A | Novel compounds as protein kinase inhibitors and pharmaceutical compositions comprising the same | 怡诺安有限公司 | 2021-07-23 | — | — | CN | disclosed |
| WO-2020101382-A1 | NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | HK INNO.N CORPORATION (KR) | 2020-05-22 | — | — | WO | disclosed |
| WO-2020101382-A1 | NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | HK INNO.N CORPORATION (KR) | 2020-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12180185-B2 | Compound as protein kinase inhibitor, and pharmaceutical composition comprising thereof | MAP3K20, MAP3K1, MAP3K15 | ACVRL1 4032/4885GSK3B 181/4885GSK3A 172/4885 |
| US-20220009902-A1 | NOVEL COMPOUND AS PROTEIN KINASE INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THEREOF | MAP3K20, MAP3K1, MAP3K15 | ACVRL1 3860/4885GSK3B 231/4885GSK3A 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.